Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filters

PublicationDisease areaApplication areaSample typeProducts

Eye, 2026
Olink proteomics profiling platform reveals inflammatory protein biomarkers in vitreous with different degrees of proliferative vitreoretinopathy

Zhao X., Han S., Jin H. et al.

Olink Target 96OphthalmologyPathophysiologyPatient StratificationVitreous Humor

International Journal of Immunopathology and Pharmacology, 2026
Mendelian randomization implicates circulating plasma proteins in gout risk and identifies candidate therapeutic targets

Zhang H., Dang Z., Yu P. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma

Annals of Hematology, 2026
Integrated transcriptome-proteome analysis in patients with myelofibrosis-related anemia

Yang L., Chen Y., Wu Y.

Olink Target 96OncologyHematologyPatient StratificationPlasma

Nature Cardiovascular Research, 2026
Large-scale identification of protein biomarkers and therapeutic targets in heart and brain disease

Wu C., Li D., Khetarpal S. et al.

Olink Explore 3072/384CVDNeurologyPathophysiologyPlasma

Metabolism, 2026
Large-scale plasma proteomics for predicting future cardiovascular and all-cause mortality among individuals with cardiovascular-kidney-metabolic syndrome stage 0–3

Weng B., Wei J., Chen H. et al.

Olink Explore 3072/384CVDNephrologyMetaboloc DiseasesPatient StratificationPlasma

Diabetes, Obesity and Metabolism, 2026
Integrated Plasma Proteomics and Functional Analyses Reveal Hepatic CDHR2 as a Potential Therapeutic Target in MASLD

Shi Y., Huang Q., Liu Y. et al.

Olink Explore 3072/384Metabolic DiseasesHepatologyPathophysiologyPlasma

Cancer Research, 2026
Ribonuclease 5/Angiogenin Suppresses Intestinal Tumor Initiation by Maintaining Crypt Homeostasis

Shi X., Chen J., Bai R. et al.

Olink Explore 3072/384OncologyCross-platform ValidationPlasma

Journal of Allergy and Clinical Immunology, 2026
Human retinoic acid–inducible gene I (RIG-I) deficiency associated with susceptibility to classic Kaposi sarcoma

Roussel L., Bernier S., Langelier M. et al.

Olink Target 96OncologyInfectious DiseasesPathophysiologyCell Culture Supernatant

Scientific Reports, 2026
Genetic predisposition to coffee consumption and the association with the early risk of atherosclerosis

Qiao X., Toma V., Wang J. et al.

Olink Target 96Olink Explore 3072/384CVDPathophysiologyPlasma

Journal of Lipid Research, 2026
Low serum sphingosine-1-phospate and its chaperone ApoM associate with retinopathy of prematurity

Nilsson A., Sjöbom U., Panwar M. et al.

Olink Target 96OphthalmologyObstericsPathophysiologySerum

Brain, Behavior, & Immunity - Health, 2025
Plasma profiles of neurology-related proteins in at-risk mental state and first-episode psychosis: Associations with psychotic symptoms and cognitive performance

Llaurador-Coll M., Montalvo I., Estrada F. et al.

Olink Target 96NeurologyWill Be: Pathophysiology & Patient StratificationPlasma

European Journal of Medical Research, 2026
Integrating inflammation-oriented brain injury mechanisms in acute COVID-19 using multi-modality MRI and serum proteomics: a longitudinal study

Lizhu Y., Sun J., Ao F. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Frontiers in Cardiovascular Medicine, 2026
Combined diagnostic value of NT-proBNP, DLK-1, PSP-D and PCSK-9 in heart failure with preserved ejection fraction: a prospective biomarker study

Xiaobin L., Yu Q., Jingjie F. et al.

Olink Target 96CVDPatient StratificationSerum

Bioengineering, 2026
Machine-Learning-Based Targeted Plasma Proteomic Analysis for Predicting Motor Progression in Parkinson’s Disease: An Interpretable Approach to Personalized Disease Management

Lin W., Grewal S.

Olink Target 96NeurologyPatient StratificationPlasma

CHEST, 2026
Matrix Metalloproteinase 12 Improves the Differentiation of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis and Associates With Antigen Response Pathways

Konkol S., Huang Y., Ma S. et al.

Olink Explore 3072/384Respiratory DiseasesPatient StratificationPlasma

European Heart Journal, 2026
Silent plaque ruptures in non-obstructive lesions of non–infarct-related arteries: a multimodality, serial intracoronary imaging study

Kakizaki R., Biccirè F., Losdat S. et al.

Olink Target 96CVDPathophysiologyPlasma

International Journal of Molecular Sciences, 2026
Modeled Aqueous Humor Protein Concentrations to Enable Biomarker Development in Uveal Melanoma

Huang E., Chen Y., Peng C. et al.

Olink Explore 3072/384Olink Target 48OncologyOphthalmologyPatient StratificationAqueous Humor

Nature Communications, 2026
Macrophage Gsα promotes NLRP3 stability and its intervention attenuates abdominal aortic aneurysm in male mice

He L., Qin X., Ren Q. et al.

Olink Target 48 MouseCVDPathophysiologyMouse Tissue Lysate

Journal of Allergy and Clinical Immunology: Global, 2026
Impact of gut microbiome, plasma metabolites, peripheral immune cells, and circulating inflammatory protein on chronic spontaneous urticaria: Bidirectional 2-sample Mendelian randomization study and mediation analysis

Deng L., Yao Y., Wang Q. et al.

Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologyPlasma

European Journal of Preventive Cardiology, 2026
Association between IL-6 and hs-CRP and cardiovascular risk in clinically relevant subgroups

Bundgaard J., Ahlberg G., Rand S. et al.

Olink Explore 3072/384CVDPatient StratificationPlasma

3795 publications